Article: In patients with a high 5 year risk of death, does simvastatin reduce mortality and vascular events?

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleIn patients with a high 5 year risk of death, does simvastatin reduce mortality and vascular events?
AuthorsKumana, CR
Cheung, BM
Lauder, IJ
KeywordsArtery Occlusion
Cancer Incidence
Cardiovascular Disease
Clinical Trial
Death
Diabetes Mellitus
Diet Restriction
Diet Supplementation
Dose Response
Drug Safety
Drug Use
Factorial Analysis
Follow Up
Heart Protection
High Risk Patient
Human
Hypertension
Ischemic Heart Disease
Malignant Neoplastic Disease
Mortality
Patient Compliance
Patient Selection
Prescription
Quality Of Life
Risk Assessment
Risk Reduction
Short Survey
Stroke
Treatment Outcome
United Kingdom
Vascular Disease
Issue Date2003
PublisherB M J Publishing Group. The Journal's web site is located at http://www.evidence-basedmedicine.com
CitationEvidence-Based Medicine, 2003, v. 8 n. 1, p. 10 [How to Cite?]
DOI: http://dx.doi.org/10.1136/ebm.8.1.10
ISSN1356-5524
2011 SCImago Journal Rankings: 0.075
DOIhttp://dx.doi.org/10.1136/ebm.8.1.10
ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorKumana, CR
dc.contributor.authorCheung, BM
dc.contributor.authorLauder, IJ
dc.date.accessioned2010-09-17T10:22:22Z
dc.date.available2010-09-17T10:22:22Z
dc.date.issued2003
dc.description.natureLink_to_subscribed_fulltext
dc.identifier.citationEvidence-Based Medicine, 2003, v. 8 n. 1, p. 10 [How to Cite?]
DOI: http://dx.doi.org/10.1136/ebm.8.1.10
dc.identifier.doihttp://dx.doi.org/10.1136/ebm.8.1.10
dc.identifier.issn1356-5524
2011 SCImago Journal Rankings: 0.075
dc.identifier.issue1
dc.identifier.scopuseid_2-s2.0-80051953944
dc.identifier.spage10
dc.identifier.urihttp://hdl.handle.net/10722/91623
dc.identifier.volume8
dc.languageeng
dc.publisherB M J Publishing Group. The Journal's web site is located at http://www.evidence-basedmedicine.com
dc.relation.ispartofEvidence-Based Medicine
dc.relation.referencesReferences in Scopus
dc.subjectArtery Occlusion
dc.subjectCancer Incidence
dc.subjectCardiovascular Disease
dc.subjectClinical Trial
dc.subjectDeath
dc.subjectDiabetes Mellitus
dc.subjectDiet Restriction
dc.subjectDiet Supplementation
dc.subjectDose Response
dc.subjectDrug Safety
dc.subjectDrug Use
dc.subjectFactorial Analysis
dc.subjectFollow Up
dc.subjectHeart Protection
dc.subjectHigh Risk Patient
dc.subjectHuman
dc.subjectHypertension
dc.subjectIschemic Heart Disease
dc.subjectMalignant Neoplastic Disease
dc.subjectMortality
dc.subjectPatient Compliance
dc.subjectPatient Selection
dc.subjectPrescription
dc.subjectQuality Of Life
dc.subjectRisk Assessment
dc.subjectRisk Reduction
dc.subjectShort Survey
dc.subjectStroke
dc.subjectTreatment Outcome
dc.subjectUnited Kingdom
dc.subjectVascular Disease
dc.titleIn patients with a high 5 year risk of death, does simvastatin reduce mortality and vascular events?
dc.typeArticle
Author Affiliations
  1. Clinical Trial Service Unit